Zdravljenje nedrobnoceličnega pljučnega raka
Pri zdravljenju pljučnega raka uporabljamo predvsem operacijo, radioterapijo in kemoterapijo, operacija pa je še vedno najučinkovitejša metoda zdravljenja pljučnega raka v zgodnji in srednji fazi. Pri centralnem pljučnem raku pa je zaradi posebne lokacije lezije tradicionalne kirurške posege težko izvajati in bolniki pogosto izgubijo možnost ozdravitve.
Central lung cancer refers to lung cancer that occurs in the bronchi, lobular bronchus, and lung bronchus, with squamous carcinoma and undifferentiated carcinoma mostly. Surgery is rarely used for central pljučni rak. This is because central lung cancer is located near the hilum. It is difficult to remove, and the surgical effect is not ideal. It is easy to induce bone metastasis . Therefore, in the past, clinicians often were helpless when treating central lung cancer.
Tudi z izboljšanjem tehnologije pljučne kirurgije je uporaba intraperikardialne pnevmonektomije v določeni meri razširila kirurške indikacije in povečala stopnjo resekcij. Vendar pa glede na klinične podatke pri zdravljenju centralnega pljučnega raka učinkovitost kirurške resekcije ni dobro ocenjena, zlasti pri bolnikih z napredovalim pljučnim rakom se kirurška resekcija na splošno odsvetuje. Zdravljenje centralnega pljučnega raka, tudi če gre za torakotomijo, je večinoma raziskovalna kirurgija in paliativna kirurgija. Starejši bolniki imajo slabo srce in težko prenašajo kirurško anestezijo.
The birth of EDGE has completely changed the dilemma of the treatment of central lung cancer. This technology can effectively remove tumor lesions in vitro and remove the central lung cancer lesions in vitro. The treatment effect can be comparable to surgical operations, but there is no surgical operation for patients. Caused by trauma and side effects.
Experts from the Global Oncologist Network introduced that EDGE, which was launched in 2014, is by far the most advanced in-vitro non-invasive tumor removal technology. It can remove tumor lesions in the body without any damage to the patient’s body and immune system. This technique is particularly suitable for patients with tumors that were previously inoperable, such as lung cancer, brain tumors, spine tumors, glava in vrat tumors, pancreatic cancer, prostate cancer and other diseases.
Male, 53 years old, suffering from nedrobnocelični pljučni rak with multiple metastatic brain tumors. In early June 2014, he went to Henry Ford Hospital for EDGE non-invasive radiosurgery. EDGE treatment 3 times, continuous daily treatment, once a day, each time takes about 12 minutes. The first time after operation, the patient’s headache was obviously relieved, and the patient is generally in good condition so far. During the follow-up in early September, the local hospital in Taipei underwent MRI examination: 0.9 and 4 cm3 tumorji v možganih almost disappeared, and 6.5 cm3 tumors in the lungs decreased by more than 98%.
Sistem EDGE Radiosurgery (EDGE radiosurgery tumor treating system) je razvilo ameriško podjetje Varian, odobrila pa ga je ameriška FDA 23. januarja 2013. EDGE je daleč najučinkovitejša neinvazivna tehnologija odstranjevanja tumorjev. Uporablja edinstven FDA Calypso® GPS za sistem Body® in sistem za spremljanje površinskega žarka, odobren 21. julija 2014, za dinamično spremljanje in zaklepanje v realnem času pri visoki frekvenci do 10 milisekund. Med zdravljenjem tumor »pobegne« v kombinaciji z novo generacijo IGRT in drugimi tehnologijami za vodenje slike ter uporablja edinstven kolimator visoke intenzivnosti HD-MLC do 2400MU/min za odstranitev tumorskega tkiva skoraj brez preostale natančnosti.
Prvi sistem EDGE na svetu se je septembra 2013 naselil v zdravstvenem sistemu Združenih držav Henry Ford (HFHS, American Henry Ford Medical Group) in začel s prvim delovanjem marca 2014.
EDGE has an excellent therapeutic effect on solid tumors such as head tumors, lung cancer including breast cancer, spine tumors, raka na jetrih and other tumors that are difficult to perform in conventional surgery. The entire treatment process is non-invasive, no anesthesia, no hospitalization, each treatment time is 8-20 minutes, once a day, up to 5 times, continuous daily treatment. EDGE treatment has almost no side effects, almost no damage to important organs, and almost no effect on the body’s anti-cancer immune system.
Prednosti neinvazivne kirurgije EDGE radiosurgery
Ø Kratek čas zdravljenja: 8-20 minut vsakič;
Ø Časi zdravljenja: skupno 1-5 krat, kontinuirano zdravljenje, enkrat na dan;
Ø Visoka učinkovitost: več tumorskih žarišč je mogoče očistiti hkrati;
Ø Sledenje pobegu in odstranitvi tumorja v realnem času: sledite in zaklenite pobeg tumorja z zelo visoko frekvenco 10 milisekund in ga odstranite;
Ø Dober učinek odstranjevanja: visoka trdnost, visoka natančnost in visoka natančnost, popolna odstranitev tumorskega tkiva skoraj brez ostankov;
Ø Skoraj ni poškodb pomembnih organov: skoraj ni poškodb pomembnih tkiv in organov;
Ø Poškodba imunskega sistema telesa proti raku ima majhen učinek: na bolnikov lastni imunski sistem skoraj ne vpliva;
Ø Priročnost: brez anestezije in brez hospitalizacije;
Ø Stranski učinki: Stranskih učinkov skoraj ni.
